Human Molecular Genetics Advance Access originally published online on March 24, 2005
Human Molecular Genetics 2005 14(10):1245-1250; doi:10.1093/hmg/ddi135
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease
1The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7BN, UK, 2Gastroenterology Unit, University of Oxford, Radcliffe Infirmary, Oxford, 3Imperial College, Hammersmith Campus, London, UK and 4Oxagen Ltd, Abingdon, Oxfordshire, UK
* To whom correspondence should be addressed. Tel: +44 1865 287651; Fax: +44 1865 287533; Email: dermot{at}well.ox.ac.uk
Received November 19, 2004; Revised March 11, 2005; Accepted March 21, 2005
The identification of the role of genetic variants within NOD2 (CARD15) in Crohn's disease and ulcerative colitis susceptibility highlight the role of the innate immune system in inflammatory bowel disease (IBD) pathogenesis. NOD1 (CARD4) is located on chromosome 7p14.3, in a region of known linkage to IBD and encodes an intracellular bacterial pathogen-associated molecular pattern receptor that is closely related to NOD2. We have identified strong association between haplotypes in the terminal exons of NOD1 and IBD (multi-allelic P=0.0000003) in a panel of 556 IBD trios. The deletion allele of a complex functional NOD1 indel polymorphism (ND1+32656*1) was significantly associated with early-onset IBD (P=0.0003) in unrelated cases and controls. ND1+32656*1 was also associated with extra-intestinal manifestations of IBD (P=0.04). These findings in two independent populations provide strong evidence for a role for NOD1 variants in IBD susceptibility and reinforce the role of the innate immune system in IBD pathogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B.G. Loos, A. Fiebig, M. Nothnagel, S. Jepsen, B. Groessner-Schreiber, A. Franke, P.M. Jervoe-Storm, K. Schenck, U. van der Velden, and S. Schreiber NOD1 gene polymorphisms in relation to aggressive periodontitis Innate Immunity, August 1, 2009; 15(4): 225 - 232. [Abstract] [PDF] |
||||
![]() |
G. Y. Chen, M. H. Shaw, G. Redondo, and G. Nunez The Innate Immune Receptor Nod1 Protects the Intestine from Inflammation-Induced Tumorigenesis Cancer Res., December 15, 2008; 68(24): 10060 - 10067. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stroh, A. Batra, R. Glauben, I. Fedke, U. Erben, A. Kroesen, M. M. Heimesaat, S. Bereswill, S. Girardin, M. Zeitz, et al. Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes J. Immunol., September 1, 2008; 181(5): 3620 - 3627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Henckaerts, M. Pierik, M. Joossens, M. Ferrante, P. Rutgeerts, and S. Vermeire Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease Gut, November 1, 2007; 56(11): 1536 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Van Limbergen, E. R. Nimmo, R. K. Russell, H. E. Drummond, L. Smith, N. H. Anderson, G. Davies, I. D. Arnott, D. C. Wilson, and J. Satsangi Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy Hum. Mol. Genet., September 15, 2007; 16(18): 2175 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Raelson, R. D. Little, A. Ruether, H. Fournier, B. Paquin, P. Van Eerdewegh, W. E. C. Bradley, P. Croteau, Q. Nguyen-Huu, J. Segal, et al. From the Cover: Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci PNAS, September 11, 2007; 104(37): 14747 - 14752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, A. Kawasaki, K. Yang, Y. Fujimoto, J. Masumoto, E. Breukink, G. Nunez, K. Fukase, and N. Inohara A Role of Lipophilic Peptidoglycan-related Molecules in Induction of Nod1-mediated Immune Responses J. Biol. Chem., April 20, 2007; 282(16): 11757 - 11764. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Sanderson and W. A. Walker TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G6 - G10. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Franke, A Ruether, N Wedemeyer, T H Karlsen, A Nebel, and S Schreiber No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. Gut, November 1, 2006; 55(11): 1679 - 1680. [Full Text] [PDF] |
||||
![]() |
J.E. den Hartog, S.A. Morre, and J.A. Land Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening Hum. Reprod. Update, November 1, 2006; 12(6): 719 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, K. Yang, M. Hashimoto, J.-H. Park, Y.-G. Kim, Y. Fujimoto, G. Nunez, K. Fukase, and N. Inohara Differential Release and Distribution of Nod1 and Nod2 Immunostimulatory Molecules among Bacterial Species and Environments J. Biol. Chem., September 29, 2006; 281(39): 29054 - 29063. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases. Gut, September 1, 2006; 55(9): 1341 - 1349. [Full Text] [PDF] |
||||
![]() |
G.-T. Ho, N. Soranzo, E.R. Nimmo, A. Tenesa, D.B. Goldstein, and J. Satsangi ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach Hum. Mol. Genet., March 1, 2006; 15(5): 797 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Masumoto, K. Yang, S. Varambally, M. Hasegawa, S. A. Tomlins, S. Qiu, Y. Fujimoto, A. Kawasaki, S. J. Foster, Y. Horie, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo J. Exp. Med., January 23, 2006; 203(1): 203 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Girardin, M. Jehanno, D. Mengin-Lecreulx, P. J. Sansonetti, P. M. Alzari, and D. J. Philpott Identification of the Critical Residues Involved in Peptidoglycan Detection by Nod1 J. Biol. Chem., November 18, 2005; 280(46): 38648 - 38656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Netea, G. Ferwerda, D. J. de Jong, C. Werts, I. G. Boneca, M. Jehanno, J. W. M. Van Der Meer, D. Mengin-Lecreulx, P. J. Sansonetti, D. J. Philpott, et al. The Frameshift Mutation in Nod2 Results in Unresponsiveness Not Only to Nod2- but Also Nod1-activating Peptidoglycan Agonists J. Biol. Chem., October 28, 2005; 280(43): 35859 - 35867. [Abstract] [Full Text] [PDF] |
||||









